Characterisation of the Novel HLA‐DRB1*12:119 Allele by PacBio Sequencing
HLA · 2026-04 · 107 (4)
DOI: 10.1111/tan.70695 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 30.03.2026. Verfasst von Shihang Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dalian Blood Center, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: HLA-DRB1 Chains, Alleles, Exons, Introns. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: Dalian Science and Technology Innovation Fund.
Abstract (Originalsprache)
HLA‐DRB1*12:119 differs from DRB1*12:02:01:01 by one nucleotide substitution in exon 5, and intronic changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dalian Blood Center, Dalian, Liaoning, China.
- College of Laboratory Medicine, Dalian Medical University, Dalian, China.
ORCID-Profile: Shihang Zhou, Wenqian Song, Xiaohua Liang
Förderung
- Dalian Science and Technology Innovation Fund
Zitieren
APA
Zhou, S., Yu, W., Bai, S., Song, W., & Liang, X. (2026). Characterisation of the Novel HLA‐DRB1*12:119 Allele by PacBio Sequencing. HLA, 107(4). https://doi.org/10.1111/tan.70695
Vancouver
Zhou S, Yu W, Bai S, Song W, Liang X. Characterisation of the Novel HLA‐DRB1*12:119 Allele by PacBio Sequencing. HLA. 2026;107(4). doi:10.1111/tan.70695
BibTeX
@article{Zhou2026,
author = {Zhou, Shihang and Yu, Wanzhen and Bai, Suning and Song, Wenqian and Liang, Xiaohua},
title = {Characterisation of the Novel HLA‐DRB1*12:119 Allele by PacBio Sequencing},
journal = {HLA},
year = {2026},
volume = {107},
number = {4},
doi = {10.1111/tan.70695}
}
EUVIMED